Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study

View through CrossRef
Abstract Background Bloodstream infections (BSI) are a major cause of morbidity, mortality, and health care costs worldwide. Population-based studies are key to assess BSI epidemiology over time while minimizing selection bias but remain limited. Therefore, we aimed to assess the incidence of BSI in a large Canadian health region in a contemporary period. We hypothesized that there would be significant age and sex-based differences including over time. Methods We conducted a retrospective cohort study from 2011 through 2018 using a population-based microbiology database to determine the annual age- and sex-specific BSI testing and case rates with the census as the population reference. BSI was defined as a positive blood culture for a pathogen. Episodes > 30 days apart were included for analysis. Incidence rate ratios (IRR) for testing and case rates including by sex were calculated to assess changes over time. All analyses were run at a two-sided α of 0.05 and were conducted with R 4.0.4. Results A total of 154,147 distinct individuals (49.9% male) were analyzed and 22,869 (14.8%) had a BSI at the first encounter in the study period. Overall BSI testing incidence ranged from 1529 to 1707 per 100,000 person-years and case incidence ranged from 180 to 292 per 100,000 person-years. Testing and case incidence for BSI was greatest in the 0-4 and 75+ years age groups (p < 0.01). Males compared to females had greater testing and case incidence rates in young and old age groups, but females had greater rates in the 15-44 years groups (p < 0.01). Overall IRR for cases comparing 2018 to 2011 was 0.62 (95% CI 0.59-0.65) reflecting a significant decrease over time. Testing also decreased over the study period with an IRR of 0.90 (95% CI 0.88-0.91). Testing and case IRRs were not significantly different stratified by sex. Incidence rates (per 100,000 person-years) of BSI testing and cases by sex from 2011 through 2018 in a Canadian health region Conclusion In our large population-based study of BSI, we identified that BSI remain frequent and the youngest and oldest age groups as well as males in these age groups have the greatest BSI incidence rates which may reflect both biological sex and gender-based differences. Encouragingly, BSI incidence rates have decreased over time at a greater increment relative to testing rates. Future studies of BSI should focus on pathogen and outcome-based evaluations. Disclosures All Authors: No reported disclosures
Title: 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
Description:
Abstract Background Bloodstream infections (BSI) are a major cause of morbidity, mortality, and health care costs worldwide.
Population-based studies are key to assess BSI epidemiology over time while minimizing selection bias but remain limited.
Therefore, we aimed to assess the incidence of BSI in a large Canadian health region in a contemporary period.
We hypothesized that there would be significant age and sex-based differences including over time.
Methods We conducted a retrospective cohort study from 2011 through 2018 using a population-based microbiology database to determine the annual age- and sex-specific BSI testing and case rates with the census as the population reference.
BSI was defined as a positive blood culture for a pathogen.
Episodes > 30 days apart were included for analysis.
Incidence rate ratios (IRR) for testing and case rates including by sex were calculated to assess changes over time.
All analyses were run at a two-sided α of 0.
05 and were conducted with R 4.
4.
Results A total of 154,147 distinct individuals (49.
9% male) were analyzed and 22,869 (14.
8%) had a BSI at the first encounter in the study period.
Overall BSI testing incidence ranged from 1529 to 1707 per 100,000 person-years and case incidence ranged from 180 to 292 per 100,000 person-years.
Testing and case incidence for BSI was greatest in the 0-4 and 75+ years age groups (p < 0.
01).
Males compared to females had greater testing and case incidence rates in young and old age groups, but females had greater rates in the 15-44 years groups (p < 0.
01).
Overall IRR for cases comparing 2018 to 2011 was 0.
62 (95% CI 0.
59-0.
65) reflecting a significant decrease over time.
Testing also decreased over the study period with an IRR of 0.
90 (95% CI 0.
88-0.
91).
Testing and case IRRs were not significantly different stratified by sex.
Incidence rates (per 100,000 person-years) of BSI testing and cases by sex from 2011 through 2018 in a Canadian health region Conclusion In our large population-based study of BSI, we identified that BSI remain frequent and the youngest and oldest age groups as well as males in these age groups have the greatest BSI incidence rates which may reflect both biological sex and gender-based differences.
Encouragingly, BSI incidence rates have decreased over time at a greater increment relative to testing rates.
Future studies of BSI should focus on pathogen and outcome-based evaluations.
Disclosures All Authors: No reported disclosures.

Related Results

Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
PS1154 INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS
PS1154 INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS
Background:Infections are a typical complication of chronic lymphocytic leukemia (CLL). Guidelines for prevention of infections in patients with CLL receiving ibrutinib is lacking,...
Invasion of chronic lymphocytic leukemia (cll/sll) bloodstream tumor cells by borrelia spirochetes
Invasion of chronic lymphocytic leukemia (cll/sll) bloodstream tumor cells by borrelia spirochetes
A sixty-six-year-old woman with a strong family history of breast cancer noted gradual onset of axillary lymph node enlargement in 2019. Axillary lymph node biopsies disclosed Lymp...
miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200
miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200
AbstractCervical cancer (CC) is a malignant solid tumor, which is one of the main causes of morbidity and mortality in women. Persistent High-risk human papillomavirus (hrHPV) infe...
Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment
Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment
Background : Patients with Chronic Lymphocytic Leukemia (CLL) are susceptible to infections due to impaired immunity, from both complications of disease and treatments. Specific tr...

Back to Top